Welcome to the website of the Research Department of the Center for Orthopaedics, Trauma Surgery and Rehabilitation Medicine.
In our research department, we work on clinically relevant topics related to modern approaches of conservative and surgical therapy of musculoskeletal diseases. We operate within a national and international network of basic scientists, engineers and physicians. The main focus of our research is the investigation of periprosthetic inflammation, the investigation and further development of orthopedic implant materials. and the application of complex human in vitro models of the musculoskeletal system.
In very rare cases, inflammation of periprosthetic tissues occurs due to infection with bacteria. These infections can be persistent because a stable bacterial biofilm can form on the implant surfaces. Bacterial infections therefore usually require implant revision and high-dose, long-term antibiotic therapy. The definite diagnosis of acute bacterial periprosthetic infection can often only be made in the postoperative course after microbiological and histopathological examination of periprosthetic tissues. Therefore, we develop concepts for earlier diagnosis of periprosthetic infections. Furthermore, we work on concepts to further reduce the numbers of early periprosthetic infections. In the course of a clinical study, we are investigating the immune status and antibody response of patients undergoing infection therapy. These concepts should help to optimally adapt antibiotic therapies with regard to dosage and therapy duration with respect to the individual patient.
In addition to bacteria-induced periprosthetic inflammation, aseptic periprosthetic inflammation can also occur in very rare cases in arthroplasty. These tissue reactions can be induced by the release of particulate and dissolved wear and corrosion products from metallic implant components. The severity of this sterile inflammation depends on the individual exposure scenario. Therefore, it is important for us to characterize locally released degradation products with respect to their physicochemical properties and to quantify the local exposure level. These analyses help to identify the clinically relevant degradation products and to better understand the associated immune responses based on ex vivo studies of periprosthetic tissues or mechanistic in vitro studies. Furthermore, we analyze the blood levels of metals relevant in arthroplasty at the time of implant revision. With the data obtained, we aim to establish threshold levels for systemic metal exposure which will help to support clinical decision making in terms of benefits for the individual patient related to revision surgery. Another aim of our work is to optimize metallic implant materials with respect to their surface characteristics. These modifications should minimize local metal release and thus enable even better biocompatibility and longevity of orthopaedic implants.
In our cell laboratory, we perform experimental research on functional consequences for cells of the musculoskeletal system induced by septic and aseptic periprosthetic inflammatory processes. To this end, we develop in vitro models based on primary human cells isolated from bone, bone marrow, cartilage, tendon and muscle. We perform standard cell-based methods to determine cellular functionality such as differentiation and migration potential. The overall aim is the application and further development of in vitro methods in the context of clinically relevant research questions, such as investigating the influence of implant materials, material degradation products, or an inflammatory periprosthetic environment on cellular functionality and viability. We further develop cell-based in vitro models to enable even more reliable analyzes of implant materials and thus to support preclinical testing algorithms of current and future implant materials.